AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer
Molecular Therapy: Oncology
· Elsevier
Аннотация
Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Tatsuki Ikoma, Keigo Araki, Mai Kitagawa, Natsuno Makihara, Yutaro Nagata, Kazuki Fujii, Yukiko Okuno, Keisuke Kamisako Yuta Okazaki, Kentaro Nakanishi, Yume Sanada, Kiyori Yoshida, Kahori Nakahama, Yuki Takeyasu, Utae Katsushima, Yuta Yamanaka, Satoshi Ikeda, Hiroshige Yoshioka, Toshio Shimizu, Takayasu Kurata
Читать у издателя →
Цитирование
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002122?dgcid=rss_sd_all
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002122?dgcid=rss_sd_all
“AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.” Molecular Therapy: Oncology.
@article{article59391,
title = {AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002122?dgcid=rss_sd_all}
}